ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658371; 2) Community: the network communities that were significantly associated with the response to NSC 658371; 3) Molecule: the relationships between components within communities and NSC 658371; 4) MDR: the compounds that were significantly associated with the NSC 658371.

NSC Compound Enrichment Correlation
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0459335986102865 0.0023888069
NSC 753734 7alpha-acetoxyroylenane 0.0459335986102865 -0.079049399
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0459335986102865 0.31729481
NSC 757387 ACRIFLAVINIUM HYDROCHLORIDE 0.0459335986102865 0.20016097
NSC 758845 Null 0.0459335986102865 0.28526728
NSC 763564 EMD-534085 0.0459335986102865 0.36040825
NSC 87500 Solacongestidine 0.0459335986102865 0.36384715
NSC 658455 (S,S)(-)3,5-Dimethoxy N-(.alpha.-Phenethyl)phenyl isopropylamine 0.0462077035966084 0.18484492
NSC 662253 Null 0.0462077035966084 0.41261017
NSC 666767 Null 0.0462077035966084 0.25597245
Total:166  Current:150    [First] [Prev] [Next] [Last]